Persistence of TEL-AML1 fusion gene as minimal residual disease has no additive prognostic value in CD 10 positive B-acute lymphoblastic leukemia: a FISH study

por Mosad, Eman, Hamed, Hosny B, Bakry, Rania M, Ezz-Eldin, Azza M, Khalifa, Nesrine M
Publicado 2008